ストックスクリーナーアプリを入手
0.8398
2.79%
0.0228
プレマーケット:
.79
-0.0498
-5.93%
前日終値:
$0.817
開ける：
$0.802
24時間の取引高:
66,416
Relative Volume:
0.41
時価総額：
$2.12M
収益：
$1.03M
当期純損益:
$-11.10M
株価収益率:
-0.0127
EPS:
-66.0832
ネットキャッシュフロー:
$-8.21M
1週間 パフォーマンス:
-12.51%
1か月 パフォーマンス:
-33.35%
6か月 パフォーマンス:
-82.94%
1年 パフォーマンス:
-97.48%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.7886
$0.9499
52週間の値動き範囲:
$0.7886
$36.32
Ispecimen Inc Stock (ISPC) Company Profile
Compare ISPC vs TMO, DHR, NTRA, A, IQV
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
0.8398 | 2.12M | 1.03M | -11.10M | -8.21M | -66.08 |
TMO
Thermo Fisher Scientific Inc
|
684.89 | 253.24B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
232.97 | 163.77B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
404.90 | 58.36B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
175.96 | 49.61B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
273.60 | 45.03B | 16.63B | 1.39B | 2.12B | 8.0674 |
Ispecimen Inc (ISPC) 最新ニュース
A 1-for-10 to 1-for-100 reverse split goes to iSpecimen (ISPC) voters October 30. - Stock Titan
iSpecimen approves AI deal as iSpecimen stock faces reverse split vote - ad-hoc-news.de
iSpecimen approves Foldlab AI deal with reverse split vote for iSpecimen stock - ad-hoc-news.de
iSpecimen Shareholders Approve Key Financing and Acquisition Actions - The Globe and Mail
More yes than no votes would approve iSpecimen (ISPC) reverse split on October 30. - Stock Titan
iSpecimen Shareholders Approve Key Financing and Acquisition Actions - TipRanks
A hospital is checking a new lab analyzer before clinical testing begins. - Stock Titan
iSpecimen Supports Hospital Validation of New Chemistry Analyzer - Yahoo Finance
Up to 80% discounts on future financings at iSpecimen (NASDAQ: ISPC) hinge on a shareholder vote. - Stock Titan
iSpecimen Granted Nasdaq Extension to Regain Compliance - The Globe and Mail
iSpecimen Granted Nasdaq Extension to Regain Compliance - TipRanks
iSpecimen Disclosed Failure to Satisfy a Continued Listing Rule or Standard - tradingview.com
ISPC Stock Holds Ground As iSpecimen Delivers Cancer Research Milestone - timothysykes.com
ISPC Stock Draws Attention After Major Cancer Research Win - StocksToTrade
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
ISPC Stock Draws Traders As Cancer Order Highlights Global Reach - timothysykes.com
ISPC Stock Draws Traders After Rapid Cancer Project Win - StocksToTrade
Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket - Benzinga
ISPECIMENDEAL VALUED AT $4.50 MLN: $2 MLN CASH, $2.50 MLN IN COMMON STOCKSEC FILING - Moomoo
iSpecimen to Acquire AI Assets from Foldlab AI for $4.5 Million - minichart.com.sg
iSpecimen to Acquire Foldlab AI Disease Analytics - TipRanks
iSpecimen (NASDAQ: ISPC) lines up reverse split and financings at up to an 80% discount - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
iSpecimen Enters Asset Purchase Agreement With FoldLab AI On September 4 - TradingView
iSpecimen to Acquire Foldlab AI Assets for $4.5 Million, Stock in 5-Year Escrow - TradingView
ISpecimenEnters Asset Purchase Agreement W - Moomoo
Five-year lock-up anchors iSpecimen (NASDAQ: ISPC) AI asset deal - Stock Titan
iSpecimen announces special shareholder meeting - Bitget
ISpecimen Inc. entered into an asset purchase agreement to acquire certain artificial intelligence software, intellectual property and related assets of Foldlab AI Ltd from Foldlab AI Ltd. for $4.5 million. - marketscreener.com
iSpecimen (ISPC) Earnings Update: The EPS Result Is Below Expectation in the Latest Session; Trading Move - vinanet.vn
iSpecimen (ISPC) Earnings Update: The EPS Result Is Below Expectation in the Latest Session; Trading Move - siam.in
iSpecimen (ISPC) Earnings Snapshot: The Available Earnings Metric Delivers a Miss under the Current Snapshot; Post-Report: Shares Finish 4.62% Down in the Latest ReadingBalance Sheet Strength - vinanet.vn
iSpecimen (ISPC) Earnings Snapshot: The Available Earnings Metric Delivers a Miss under the Current Snapshot; Post-Report: Shares Finish 4.62% Down in the Latest ReadingBuyback Announcement Report - vinanet.vn
iSpecimen completes cancer research project in three weeks By Investing.com - Investing.com Nigeria
iSpecimen completes cancer research project in three weeks By Investing.com - Investing.com Canada
iSpecimen completes cancer research project in three weeks - Investing.com
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks - The Manila Times
iSpecimen completes cancer research project in three weeks By Investing.com - Investing.com UK
iSpecimen Delivers Hundreds of International Cancer Blood Specimens Within Three Weeks, Highlighting Biospecimen Network Capabilities - kalkine.ca
iSpecimen (ISPC) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session - dars.gov.et
iSpecimen (ISPC) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session - vinanet.vn
iSpecimen (ISPC) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session - dars.gov.et
An online marketplace sent hundreds of cancer samples abroad in three weeks - Stock Titan
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks - Yahoo Finance
iSpecimen (ISPC) Close in Focus: Gains 8.84% to Reach $2.34; Price Context: the Supplied Trading Band Runs From $2.22 to $2.46 in the Available RecordLong Term Entry Picks - vinanet.vn
iSpecimen (ISPC) Close in Focus: Gains 8.84% to Reach $2.34; Price Context: the Supplied Trading Band Runs From $2.22 to $2.46 in the Available RecordContinuation Pattern Picks - siam.in
iSpecimen (ISPC) Close in Focus: Gains 8.84% to Reach $2.34; Price Context: the Supplied Trading Band Runs From $2.22 to $2.46 in the Available RecordElliott Wave Count - dars.gov.et
iSpecimen Inc. (ISPC) Pulls Back 2.81% to $2.25 as Traders Eye Key Support ZoneCall Dominated - vinanet.vn
iSpecimen Inc. (ISPC) Slips 2.81% as Shares Test Key Technical LevelsPrice Momentum Stocks - dars.gov.et
iSpecimen Inc. (ISPC) Pulls Back 2.81% to $2.25 as Traders Eye Key Support ZoneTrend Continuation Trade - dars.gov.et
Ispecimen Inc (ISPC) 財務データ
収益
当期純利益
現金流量
EPS
1.07%
13.88%
大文字化:
|
ボリューム (24 時間):